Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$992,857,195
+$141,463,664 QoQ
Shares Held
3,945,546
+0.8% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#52
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sumitomo Mitsui Trust Group, Inc. holds $7,122,175,515 across 9 Drug Manufacturers - General names. ABBV ranks #3 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,895,765 | $2,273,837,603 | |
| 2 | JNJ |
Johnson & Johnson
|
5,660,854 | $1,437,687,090 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
3,945,546 | $992,857,195 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,169,107 | $792,730,249 | |
| 5 | AMGN |
Amgen Inc
|
1,520,877 | $550,739,979 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,962,648 | $374,300,948 | |
| 7 | PFE |
Pfizer Inc
|
13,775,929 | $331,724,370 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,092,121 | $293,408,012 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $992,857,195 | 3,945,546 | Shares | Defined | 2026-07-30 | |
| 2026-03-31 | $851,393,531 | 3,914,633 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $937,459,054 | 4,102,845 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $985,450,679 | 4,256,071 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $777,694,527 | 4,189,713 | Shares | Defined | 2025-07-31 | |
| 2025-03-31 | $859,786,272 | 4,103,600 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $730,979,789 | 4,113,561 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $813,466,527 | 4,119,235 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $699,866,949 | 4,080,381 | Shares | Defined | 2024-07-19 | |
| 2024-03-31 | $795,300,080 | 4,367,381 | Shares | Defined | 2024-04-19 | |
| 2023-12-31 | $686,275,191 | 4,428,439 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $662,406,541 | 4,443,892 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $605,191,531 | 4,491,884 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $821,461,190 | 5,154,428 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $847,828,523 | 5,246,139 | Shares | Defined | 2023-01-30 | |
| 2022-09-30 | $704,311,666 | 5,247,833 | Shares | Defined | 2022-10-21 | |
| 2022-06-30 | $809,345,072 | 5,284,311 | Shares | Defined | 2022-07-26 | |
| 2022-03-31 | $925,550,347 | 5,709,397 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $839,784,379 | 6,202,248 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $771,768,320 | 7,154,615 | Shares | Defined | 2021-10-25 | |
| 2021-06-30 | $803,650,580 | 7,134,682 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $829,635,406 | 7,666,193 | Shares | Defined | 2021-04-30 | |
| 2020-12-31 | $827,566,488 | 7,723,439 | Shares | Defined | 2021-02-05 | |
| 2020-09-30 | $733,424,003 | 8,373,376 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $804,513,526 | 8,194,271 | Shares | Defined | 2020-07-27 | |
| 2020-03-31 | $500,130,131 | 6,564,249 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||